BCI at the NCRI Conference, 6-9 November 2011
 |
 |
BCI will be exhibiting at the
7th NCRI Cancer Conference, Liverpool, UK
6-9 November 2011
Come and see us on stand no. 67
BCI researchers will be presenting a variety of sessions, presentations and posters, please see below for details.
Monday 7 November 2011
Parallel Sessions
- The 'Centre of the Cell' and its role in science education
Frances Balkwill
Poster Session A
- A28 - Acquired paclitaxel resistance increases oncolytic adenovirus delivery and efficacy in ovarian cancer
Carin K. Ingemarsdotter, Sarah K. Baird, Laura A. Tookman, Katrina J. Pirlo, Iain A. McNeish - A172 - The adenoviral assembly protein L4-100k is a critical effector of adenoviral induced cell death in murine cancer cells
Kyra Archibald, Anna Mary Young, Alexander Pool, Katrina Pirlo, Iain McNeish - A214 - Stromal entrapment of immune cells in pancreatic ductal adenocarcinoma
Abasi Ene-Obong, Andrew J. Clear, Alan G. Ramsay, Adam Woolf, John G. Gribben, Hemant M. Kocher - A215 - Heterogeneity in triple negative breast cancers: C-met identifies aggressive breast cancer in British-Black women
Rebecca Bowen, C Ho-Yen, R Vaziri, J Hulit, D Ryan, M Ornstein, Y White, C Choy, S Kermorgant, JL Jones - RH1 - The different genetic alterations between Western and Chinese prostate cancers indicate the aetiology
Xueying Mao, Nuria Coll Bastus, Lara Boyd, Yongwei Yu, Guoping Ren, Lius Beltran, Tim Oliver, Bryan Young, Daniel Berney, Yong-Jie Lu - LB81 - Recurrent chromosomal rearrangement in prostate cancer at the ATRNL1 gene locus on 10q26
Elzbieta Stankiewicz, Xueying Mao, Lara Boyd, Tracy Chaplin, Sakunthala Kudahetti, Liyan Xue, Dongmei Lin, Bryan Young, Daniel Berney, Yong-Jie Lu
Tuesday 8 November 2011
Proffered Paper Sessions - Cancer cell and model systems II
- Role of autocrine TNF in pancreatic tumour progression
Maud Bossard, Eleni Maniati, Natalie Cook, David Tuveson, Frances Balkwill, Thorsten Hagemann
Parallel Sessions - Phosphoinositol signalling and cancer
- Introduction: Phosphoinositol signalling and cancer
Bart Vanhaesebroeck - Direct and indirect actions of PI 3-kinase in cancer
Bart Vanhaesebroeck
Symposia - The diagnostic and therapeutic potential of the tumour microenvironment
- Introduction: The diagnostic and therapeutic potential of the tumour microenvironment
Thorsten Hagemann
Poster Session B
- B168 - Phosphoproteomics analysis of leukaemia cells identifies novel activation markers of kinases targeted by MEK, PI3K and JAK inhibitors and suggests a mechanism of resistance to such compounds
Pedro Cutillas - B190 - Role of autocrine TNF in pancreatic tumour progression
Maud Bossard, Eleni Maniati, Natalie Cook, David Tuveson, Frances Balkwill, Thorsten Hagemann - B193 - RhoC interacts with integrin a5ß1 and enhances its trafficking in migrating carcinoma cells?
Emilios Gemenetzidis, Ningfeng Fiona Li, Francis J Marshall, Derek Davies, Yongwei Yu, Kristopher Frese, Fieke EM Froeling, Adam K Woolf, Roger M, M Feakins, Yoshiki Naito, Christine Iacobuzio-Donahue, David A Tuveson, Ian R Hart, Hemant M Kocher - B204 - The possibilities of HDAC inhibition as a therapeutic strategy in pancreatic cancer
Mohammed A Ghallab, Helen C Hurst, Ian R Hart, Satya Bhattacharya, Hemant M Kocher - B243 - Monoclonal origin of multifocal cancer and the step-wise genetic events of prostate carcinogenesis
Xueying Mao, Lara Boyd, Liyan Xue, Dongmei Lin, Tracy Chaplin, Lius Beltran, Greg Shaw, John Hines, Tim Oliver, Daniel Berney, Bryan Young, Yong-Jie Lu -
Emilios Gemenetzidis, Ningfeng Fiona Li, Francis J Marshall, Derek Davies, Yongwei Yu, Kristopher Frese, Fieke EM Froeling, Adam K Woolf, Roger M ...
- LB132 - Polo-like Kinase 2 as a potential therapeutic target for MSH2 deficient cancer
Parvati Addingadoo, Madeleine Hewish, Christopher Lord, Alan Ashworth, Sarah Martin - LB146 - Bioinformatics portal for the Breast Cancer Campaign Tissue Bank
Rosalind Cutts, Philip Quinlan, Andrew Green, Valerie Speirs, Louise Jones, Claude Chelala
